5min chapter

Breakpoints cover image

#82 – ID Literature Year in Review (LIVE from MAD-ID)

Breakpoints

CHAPTER

Jepotidicin for Uncomplicated Urinary Tract Infection

Jepotidicin is a novel first in class oral antibiotic. It does inhibit DNA dry race and topo rice on race four. But notably, vancomyper sensitivity but protect against AKI. And this is a space we sorely need a drug, right? In the beautiful 2019 AMR reports that came out before COVID, we had made tremendous gains removing some of these resistant organisms. We saw KPC going down, Astaneda going down to Pseudomonas aeruginosus. I think what went up was community acquired infections like ESBLs which are associated with non-drugresistant E. coli. The biggest risk factors for having a multi-drug

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode